GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (FRA:JC4) » Definitions » YoY EPS Growth

Universal Ibogaine (FRA:JC4) YoY EPS Growth : 0.00% (As of Jan. 2025)


View and export this data going back to 2022. Start your Free Trial

What is Universal Ibogaine YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Universal Ibogaine's YoY EPS Growth for the quarter that ended in Jan. 2025 was 0.00%.

Universal Ibogaine's Earnings per Share (Diluted) for the three months ended in Jan. 2025 was €0.00.


Universal Ibogaine YoY EPS Growth Historical Data

The historical data trend for Universal Ibogaine's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Ibogaine YoY EPS Growth Chart

Universal Ibogaine Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Jul22 Jul23 Jul24
YoY EPS Growth
Get a 7-Day Free Trial 14.29 -233.33 -130.00 84.78 -

Universal Ibogaine Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 100.00 - - - -

Universal Ibogaine YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Universal Ibogaine's YoY EPS Growth for the fiscal year that ended in Jul. 2024 is calculated as:

YoY EPS Growth (A: Jul. 2024 )
=(Earnings per Share (Diluted) (A: Jul. 2024 )-Earnings per Share (Diluted) (A: Jul. 2023 ))/ | Earnings per Share (Diluted) (A: Jul. 2023 ) |
=(-0.007--0.007)/ | -0.007 |
=0.00 %

Universal Ibogaine's YoY EPS Growth for the quarter that ended in Jan. 2025 is calculated as:

YoY EPS Growth (Q: Jan. 2025 )
=(Earnings per Share (Diluted) (Q: Jan. 2025 )-Earnings per Share (Diluted) (Q: Jan. 2024 )) / | Earnings per Share (Diluted) (Q: Jan. 2024 )) |
=(0-0)/ | 0 |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Universal Ibogaine YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Universal Ibogaine's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Universal Ibogaine Business Description

Traded in Other Exchanges
Address
C/o Cas Corporate Governance Services Inc, 815 - 8th Avenue South west, Suite 600, Calgary, AB, CAN, T2P 3P2
Universal Ibogaine Inc is in the initial stages of implementing and financing its business plan, which is to develop a network of addiction treatment clinics and to undertake a planned clinical trial for research in Canada into the use of ibogaine, a natural plant-based substance, for addiction treatment. Its mission is to redefine the addiction recovery experience, providing those living with addiction the best possible recovery.

Universal Ibogaine Headlines

No Headlines